lunes, 27 de enero de 2020

Outbreak could interfere with pharma supply chain

The Readout
Damian Garde & Meghana Keshavan

Outbreak could interfere with pharma supply chain

Worldwide pandemic is the primary concern about the current coronavirus outbreak, no doubt. But the shutdowns resulting from the pathogen’s spread could have a downstream effect on health care, as well: The pharmaceutical industry may see disruption in its supply chain. After all, China’s a primary global player in the market for active pharmaceutical ingredients, STAT’s Ed Silverman writes.
Although the central hub for China’s ingredient production is far from Wuhan — the outbreak’s epicenter — more lockdowns may occur as the virus proliferates. 
“The time to worry is now,” one global quality compliance expert told STAT. 

No hay comentarios: